Philips Archives | Page 33 of 43

Home / Posts tagged Philips (Page 33)

Masimo and Philips Licensing Agreement Brings Masimo NomoLine® Capnography and O3® Regional Oximetry to Select Philips Patient Monitors

Amsterdam, the Netherlands and Irvine California, May 27 (Korea Bizwire) – Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG; AEX: PHIA), both global leaders in patient monitoring, announced today that they have reinforced their partnership, whereby Philips will integrate additional Masimo measurement technologies into select IntelliVue® MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status. Core Masimo [...]

Philips Launches next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance for COVID-19

Amsterdam, the Netherlands, May 26 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital. The next generation wireless [...]

Philips Launches HealthSuite Clinical Trial Accelerator to Help Life Science Organizations Run More Flexible, Patient-centric Clinical Trials

Amsterdam, the Netherlands, May 19 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to integrate, analyze and store clinical and patient-reported data from multiple sources, providing actionable insights for better, faster decision-making. [...]

Philips Receives FDA Clearance for the Use of its Ultrasound Portfolio to Manage COVID-19-related Lung and Cardiac Complications

Amsterdam, the Netherlands, May 13 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a wide range of its ultrasound solutions for the management of COVID-19-related lung and cardiac complications. Handheld and portable [...]

Philips to Convene Extraordinary General Meeting of Shareholders

Amsterdam, the Netherlands, May 7 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will convene an Extraordinary General Meeting of Shareholders (EGM) and publish the agenda with explanatory note shortly. The sole purpose of the EGM is submit to Philips’ shareholders the revised proposal, as announced on April 20, 2020, to declare [...]

Philips First of its Kind Ultrasound Solution for Pediatric Assessment Provides a Gentler Approach to Imaging Children

Amsterdam, the Netherlands, May 6 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the ultimate ultrasound solution for pediatric assessment, the latest addition for its Philips Ultrasound System (EPIQ Elite). The new ultrasound solution provides clinicians with exceptionally detailed images and the performance they need to make a definitive [...]

Philips Annual General Meeting of Shareholders Approves All Proposals

Amsterdam, the Netherlands, April 30 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (2020 AGM) has approved the appointment of Feike Sijbesma and Peter Löscher and the re-appointment of Neelam Dhawan as members of the Supervisory Board. The other proposals voted on at the AGM were also adopted. [...]

FDA Lifts Injunction on Manufacture and Distribution of Philips’ Defibrillators in the U.S.

Amsterdam, the Netherlands, April 24 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today that its Emergency Care and Resuscitation (ECR) business is resuming manufacturing and shipping of external defibrillators for the US, following notification from the US Food and Drug Administration (FDA) that the injunction prohibiting those activities [...]

Philips Delivers Q1 Sales of EUR 4.2 Billion, with 2% Comparable Sales Decrease; Income from Continuing Operations Amounted to EUR 42 Million and Adjusted EBITA Margin was 5.9%

Amsterdam, NETHERLANDS, April 20 (Korea Bizwire) - First-quarter highlights • Sales amounted to EUR 4.2 billion, with a 2% comparable sales decrease • Comparable order intake increased 23% • Income from continuing operations was EUR 42 million, compared to EUR 171 million in Q1 2019 • Adjusted EBITA margin was 5.9% of sales, compared to [...]

Philips Teams with University of Kentucky’s UK HealthCare to Power State’s Only eICU Clinical Command Center

Amsterdam, the Netherlands and Lexington, KY, U.S., April 15 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and UK HealthCare, the clinical enterprise of the University of Kentucky, today announced a collaboration to create Kentucky’s only operating clinical command center for tele-critical care and operational optimization. Leveraging Philips’ acute telehealth platform, eCareManager, [...]